Global Life Science Market Report 2026: Size, Trends and Forecast to 2030 | Secure $200.6B AI and Precision Medicine Upside with Johnson & Johnson, Roche, Pfizer, and AstraZeneca
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Life Science Market Report 2026" has been added to ResearchAndMarkets.com's offering.
The global life science market is experiencing rapid expansion, supported by rising pharmaceutical research and development investment, biotechnology innovation, laboratory automation, and growing demand for advanced diagnostics. The market is projected to increase from $109.53 billion in 2025 to $123.41 billion in 2026, representing a compound annual growth rate of 12.7%.
Looking ahead, the life science market is forecast to reach $200.59 billion by 2030, expanding at a compound annual growth rate of 12.9%. Growth is expected to be driven by advances in precision medicine, the continued development of digital health solutions, and the integration of artificial intelligence and big data analytics into research and clinical decision-making. Expanding global clinical trials and stronger collaboration between academic institutions, healthcare organizations, and commercial research companies are also expected to support market development.
Key life science industry trends include advanced drug discovery platforms, integrated clinical trial management systems, high-throughput laboratory automation, regulatory and compliance services, and increased use of bioinformatics and data analytics. These technologies are helping organizations improve research productivity, accelerate product development, manage complex biological data, and bring new therapies and diagnostic solutions to market more efficiently.
The increasing prevalence of chronic diseases remains a major life science market growth driver. Poor nutrition, physical inactivity, obesity, and aging populations are contributing to a greater long-term disease burden. In response, life science organizations are investing in new therapies, biologics, diagnostics, medical technologies, and research tools designed to improve disease prevention, monitoring, treatment, and patient outcomes. According to the Centers for Disease Control and Prevention, 76.4% of U.S. adults-approximately 194 million people-reported having at least one chronic condition in 2023.
Product innovation is also strengthening growth across the biotechnology and nutraceutical segments. Companies are developing clinically supported peptide-based functional ingredients for glucose regulation and metabolic health. In December 2025, Greenyn Biotechnology Co. Ltd. launched Insumate mcIRBP-19 Bitter Melon Peptide for dietary supplement applications. The bitter melon-derived peptide is designed to support blood glucose control and metabolic health. It is manufactured using a low-temperature supercritical extraction process intended to preserve peptide bioactivity and product consistency. Clinical validation and international certifications position the ingredient to address rising demand within the metabolic health and diabetes-support market.
Strategic acquisitions are reshaping the competitive environment as organizations seek broader capabilities in healthcare communications, medical education, analytics, and pharmaceutical marketing. In October 2025, MJH Life Sciences acquired BPD Healthcare for an undisclosed amount. The transaction expanded MJH Life Sciences' ability to serve pharmaceutical companies, life science organizations, healthcare professionals, and other industry audiences through enhanced communications and strategic medical marketing services.
Tariffs are creating additional cost pressures for imported laboratory instruments, reagents, analytical equipment, biotechnology products, and medical devices. The impact is particularly significant in Europe and Asia-Pacific, where parts of the market depend on foreign manufacturing and international supply chains. However, these pressures are also encouraging local manufacturing, regional supply-chain investment, and adoption of domestically developed digital health platforms and research software. These shifts may reduce import dependence while supporting regional innovation and long-term life science industry resilience.
Markets Covered:
1) By Type: Biotechnology; Pharmaceuticals; Medical Devices; Life Science Tools; Digital Health Solutions
2) By Therapeutic Areas: Oncology; Cardiology; Neurology; Immunology; Rare Diseases; Other Therapeutic Areas
3) By Applications: Drug Discovery and Development; Diagnostics; Therapeutics; Clinical Trials; Research and Development
4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Academic and Research Institutions; Hospitals and Clinics
Subsegments:
1) By Biotechnology: Genetic Engineering; Cell Based Technologies; Microbial Biotechnology; Industrial Biotechnology; Agricultural Biotechnology
2) By Pharmaceuticals: Prescription Drugs; Over The Counter Drugs; Generic Drugs; Branded Drugs; Specialty Drugs
3) By Medical Devices: Diagnostic Devices; Therapeutic Devices; Surgical Instruments; Monitoring Devices; Implantable Devices
4) By Life Science Tools: Laboratory Instruments; Reagents and Consumables; Analytical Tools; Sample Preparation Tools; Research Software Solutions
5) By Digital Health Solutions: Health Information Systems; Remote Patient Monitoring; Mobile Health Applications; Clinical Decision Support Systems; Healthcare Data Analytics
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
The companies featured in this Life Science market report include:
For more information about this report visit https://www.researchandmarkets.com/r/3cp088
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.